Charles Schwab Investment Management Inc Lifevantage Corp Transaction History

Charles Schwab Investment Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$6.9 - $9.59 $193,979 - $269,603	-28,113 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$8.58 - $10.21 $291,659 - $347,068	-33,993 Reduced 54.73%	28,113 $263,000
Q3 2020 Nov 13, 2020	BUY	$12.07 - $15.31 $216,040 - $274,033	17,899 Added 40.49%	62,106 $750,000
Q2 2020 Aug 14, 2020	BUY	$10.25 - $16.54 $100,552 - $162,257	9,810 Added 28.52%	44,207 $598,000
Q1 2020 May 15, 2020	SELL	$7.91 - $16.96 $303,427 - $650,585	-38,360 Reduced 52.72%	34,397 $355,000
Q3 2019 Nov 08, 2019	BUY	$10.8 - $14.6 $414,288 - $560,056	38,360 Added 111.52%	72,757 $997,000
Q2 2019 Aug 09, 2019	BUY	$10.68 - $14.55 $367,359 - $500,476	34,397 New	34,397 $447,000

3.85M

43.5K

2.3K

Ticker LFVN
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 12,560,000
Market Cap $275M
Description
LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.